Loading...

Konica Minolta to buy US cancer-testing company

 03-Jul-17, Nikkei Asian Review

Japan's Konica Minolta plans to acquire Ambry Genetics of the US, which uses genetic data to screen for cancer. The acquisition is expected to cost an estimated JPY100 billion yen (USD889 million).

Konica Minolta to buy US cancer testing company (c) Konica Minolta

Image: Konica Minolta

It is expected to be the office equipment maker's most expensive acquisition - one that it will make by partnering with the public-private Innovation Network Corp of Japan.

Konica has been struggling to boost its flagship multifunctional printer business. The acquisition, though, will bring the company further into the healthcare sector and give it a new revenue source.

 Read the full article 

 Insights 

Share